Editas Medicine to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following upcoming investor conferences:

• Wells Fargo 2021 Virtual Healthcare ConferenceFireside Chat (Virtual)Date: Friday, September 10, 2021Time: 8:00 a.m. ET

• Morgan Stanley 19th Annual Global Healthcare ConferenceFireside Chat (Virtual)Date: Tuesday, September 14, 2021Time: 9:30 a.m. ET

The events will be webcast live and can be accessed on the Editas Medicine website in the Investors section. Archived recordings will be available for approximately 30 days following the events.

About Editas MedicineAs a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:MediaCristi Barnett(617) 401-0113 [email protected]

InvestorsRon Moldaver(617) 401-9052[email protected]

You May Also Be Interested In

• Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition
• FirstFarms A/S’ interim financial report 1 January – 30 June 2026
• Sistaco Reviews – 3-Colour or 6-Colour Set, Which Fits?